A Quantitative Framework to Identify and Prioritize Opportunities in Biomedical Product Innovation: A Proof-of-Concept Study.

ABSTRACT:

Importance

Prioritization and funding for health initiatives, including biomedical innovation, may not consistently target unmet public health needs.

Objective

To (1) develop a quantitative, databased framework to identify and prioritize opportunities for biomedical product innovation investments based on a multicriteria decision-making model (MCDM) that includes comprehensive measures of public health burden and health care costs, and (2) pilot test the model.

Design, setting, and participants

The Department of Health and Human Services (HHS) convened public and private experts to develop a model, select measures, and complete a longitudinal pilot study to identify and prioritize opportunities for investment in biomedical product innovations that have the greatest pu

SUBMITTER: Gressler LE 

PROVIDER: S-EPMC10163391 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature